Impairment of the trans-Golgi-Lysosomal Pathway Accelerates Dopaminergic Neuronal Senescence in LRRK2R1627P Rats
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Aging and Disease in Aging and disease
- Vol. 16 (5) , 3089-3111
Abstract
Leucine-rich repeat kinase 2 (LRRK2)-R1628P mutation has been shown to be one of the common risk factors for Parkinson’s disease (PD) in Asian populations, but the mechanism by which R1628P mutations cause neuronal dysfunction remains unknown. We used LRRK2R1627P knock-in rats (human LRRK2-R1628P corresponds to rat LRRK2-R1627P) to investigate the R1627P mutation on function of dopaminergic neurons (DANs) and their susceptibility to the environmental toxin Lipopolysaccharide (LPS) during aging. LRRK2R1627P rats showed no significant loss of DANs, dopamine and its metabolites, or motor dysfunction; however, spontaneous exploration and olfactory discrimination reduced, and dendritic spines of DANs showed degeneration. We found decreased pThr73-Rab10 located on the trans-Golgi, disrupted Golgi structure and lipofuscin accumulation in aged LRRK2R1627P rat DANs, and the protein related to trans-Golgi complex and regulating lysosome function were significantly reduced. Although the neuroinflammation of brain was not obvious in the aging process, we confirmed a decrease in the ratio of CD4+/CD8+ and B cells, an increase in inflammatory factors (TLR4, NFKB, TNF-α) in the periphery. Furthermore, we demonstrated that the R1627P mutation caused the abnormal accumulation of α-Syn in the aged rat intestine. LPS exacerbated pathological α-Syn aggregation in the small intestine of LRRK2 transgenic rats and spread to the brain via the gut-brain axis. This led to microgliosis in the substantia nigra, creating a pro-inflammatory environment and inducing DANs degeneration. Gut-brain axis disruption may be a key determinant of progression to R1628P-PD in R1628P carriers. This insight has important clinical implications and highlights the importance of monitoring and addressing gut-brain axis integrity in individuals with LRRK2 mutations.Keywords
This publication has 60 references indexed in Scilit:
- R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsActa Neuropathologica, 2021
- The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriersMovement Disorders, 2016
- Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodentsBehavioural Brain Research, 2015
- Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson DiseaseJAMA Neurology, 2015
- Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- A murine model of mild traumatic brain injury exhibiting cognitive and motor deficitsJournal of Surgical Research, 2013
- The novel object recognition memory: neurobiology, test procedure, and its modificationsCognitive Processing, 2011
- Lgl1 Activation of Rab10 Promotes Axonal Membrane Trafficking Underlying Neuronal PolarizationDevelopmental Cell, 2011
- Simple Behavioral Assessment of Mouse OlfactionCurrent Protocols in Neuroscience, 2009